Messe Muenchen India’s leadership and senior industry figures used the inaugural plenary to argue that India’s manufacturing edge must now be defended with quality, data integrity and automation, not scale alone.
The 12th Pharma Pro&Pack Expo opened on the morning of 9 July with an inaugural session that leaned less on ceremony than on strategy. Presiding over the proceedings was Bhupinder Singh, Chief Executive Officer of Messe Muenchen India and the organiser’s President for the India, Middle East and Africa region, who set the tone by casting South India’s manufacturing networks as being in transition — from a model built on volume-driven production toward one competing on value-driven innovation.
That framing recurred through the opening addresses. Senior industry voices reported to have spoken at the inaugural — among them Madan Mohan Reddy, Whole-Time Director at Aurobindo Pharma, and Shirish Belapure, Senior Technical Advisor to the Indian Pharmaceutical Alliance — pressed a consistent argument: that the integration of analytical rigour with manufacturing practice has become a precondition for holding export margins as international regulators tighten their expectations. Continuous validation, digital data integrity and stringent contamination control, the session heard, can no longer be treated as aspirational add-ons; they must become default features of the plant floor if Indian producers intend to preserve global trust.
Hyderabad as the natural stage
The regional theme was unmistakable. Speakers returned repeatedly to Hyderabad’s outsized role in India’s bulk-drug and API output, and to the logic of convening a flagship processing-and-packaging exhibition in the city where so many of its buyers operate. The message to the international technology suppliers filling the International Pavilion was direct: the primary decision-makers of Indian generics and formulations were in the building, and the competitiveness of their plants over the next five years would be decided by the systems on display in these halls.
Underlying the addresses was an alignment with national policy — the Aatmanirbhar Bharat push toward self-reliant manufacturing — read alongside the revised Schedule M standards now reshaping Indian good-manufacturing-practice requirements. The inaugural did not treat these as competing pressures. Rather, the argument advanced was that domestic ambition and international compliance point in the same direction: toward smarter, better-instrumented, more tightly controlled production.
A note on the record
In the interest of accuracy, this desk records that a full, verbatim transcript of the inaugural speeches was not publicly archived at the time of filing; the account above reflects the named participants and the substance of their remarks as documented in the show’s materials, without attributing specific quotations that cannot be independently confirmed. What is beyond dispute is the direction of travel the session set for the three days that followed — an agenda in which technology was consistently framed as the means to a regulatory and commercial end, not an end in itself.
–Naresh Teeguntla
